U.S. market Closed. Opens in 16 hours 23 minutes

PRTK | Paratek Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue150.79M120.95M43.52M16.54M17.12M12.62M29.00KN/A4.34M1.75M11.03M19.69M12.50M5.21M60.62M16.68M371.00K56.00K1.12M1.33M371.00KN/A
Cost of Revenue23.06M21.54M8.65M3.48MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit127.73M99.42M34.87M13.06M17.12MN/AN/AN/AN/AN/AN/A19.69M12.50M5.21M60.62MN/AN/AN/AN/AN/AN/AN/A
Operating Expenses173.94M140.55M110.37M128.69M121.17M97.04M109.86M70.75M10.86M26.16M22.88M23.46M21.72M25.05M28.58M53.33M33.12MN/AN/AN/AN/AN/A
Selling, General & Admin145.60M119.40M89.86M89.14M63.66M36.97M26.40M19.99M5.85M19.25M11.69M12.19M11.04M16.05M16.90M17.28M11.31M7.25M5.21MN/A2.21M602.00K
Research & Development37.82M30.35M23.92M39.55M57.51M60.07M83.46M50.77M5.01M6.90M11.19M11.27M10.68M9.01M11.68M36.05M21.81M17.67M14.69MN/A4.04M1.04M
Other Operating Expenses-9.48M-9.21M-3.41M-31.00K-44.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-46.21M-41.13M-75.50M-115.63M-104.08M-84.58M-109.83M-70.75M-6.52M-24.41M-11.86M-3.76M-9.22M-19.85M32.04M-36.65M-32.74M-24.86M-18.78M1.33M-5.88M-1.65M
Other Expenses / Income-17.30M-17.35M-21.04M-12.86M-80.00K-3.74M-1.80M-107.00K-11.31M-3.04M-159.00K-186.00K-196.00K-2.06MN/AN/AN/AN/AN/AN/AN/AN/A
Before Tax Income-63.51M-58.48M-96.54M-128.49M-111.85M-88.32M-111.64M-70.86M-17.84M-27.45M-12.02MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses57.00K600.00K19.72M301.00K502.00K753.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-63.57M-59.08M-116.26M-128.79M-112.36M-89.07M-111.64M-70.86M-17.84M-27.45M-12.02M-3.88M-9.30M-21.80M34.82M-32.53M-29.63M-23.80M-17.95M-12.78M-5.64M-1.58M
Interest Expenses18.12M17.41M20.24M16.40M10.98M5.08M3.22M770.00K718.00KN/AN/A9.00K12.00K179.00KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding54.39M48.42M44.17M32.79M31.51M26.83M20.25M16.50M2.53M1.56M1.42M1.13M1.12M1.01M86.05K402.63K249.85K23.30K18.07K15.05K13.58K11.80K
Diluted Shares Outstanding54.39M48.42M44.17M32.79M31.51M26.83M20.25M16.50M2.53M1.56M1.42M1.13M1.12M1.01M86.40K402.63K249.85K23.30K18.07K15.05K13.58K11.80K
EBITDA-44.90M-40.69M-73.93M-112.09M-100.83M-81.97M-106.11M-70.04M-16.92M-27.36M-11.79M-3.51M-8.79M-21.07M35.94M-32.02M-28.93M-23.28M-17.86M-12.78M-5.64M-1.65M
EBITDA Margin-29.78%-33.64%-169.89%-677.50%-589.08%-649.72%-365,896.55%0.00%-389.71%-1,565.88%-106.90%-17.84%-70.33%-404.59%59.29%-191.90%-7,799.19%-41,578.57%-1,595.00%-960.53%-1,519.14%0.00%
EBIT-45.39M-41.08M-76.30M-112.09M-100.87M-83.24M-108.41M-70.09M-17.12M-27.45M-12.02M-3.87M-9.29M-21.62M34.82M-32.53M-29.63M-23.80M-17.95M-12.78M-5.64M-1.58M
EBIT Margin-30.10%-33.96%-175.34%-677.50%-589.29%-659.77%-373,837.93%0.00%-394.22%-1,571.04%-108.98%-19.66%-74.33%-415.15%57.44%-194.99%-7,985.98%-42,508.93%-1,602.86%-960.53%-1,519.14%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙